This CDR2 Antibody (33) is useful for Western blot, Immunoprecipitation, Immunohistochemistry on paraffin-embedded sections and ELISA. In Western blot, a single or double band can be seen around 55 kDa representing CDR2. In IHC-P, heavy nuclear staining was observed with some cytoplasmic signal in human breast cancer. Prior to immunostaining paraffin tissues, antigen retrieval with sodium citrate buffer (pH 6.0) is recommended.
CDR2, also known as cerebellar degeneration-related protein 2 and Yo, is a tumor antigen which has been linked to a rare disorder known as Paraneoplastic cerebellar degeneration (PCD). CDR2 is expressed in a high percentage of ovary and breast tumors and has been shown as the target antigen of a naturally occurring tumor immune response in PCD patients. Additionally, a connection has been reported between CDR2 and attenuation of tumor hypoxia signaling in the papillary subtype of renal cell carcinoma (Balamurugan K et al., 2009).
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
FAQs for CDR2 Antibody (NBP2-10509). (Showing 1 - 1 of 1 FAQ).
I'm looking for an antibody against human CDR2 to recognize thymic epithelial cells. You have several anti CDR2 antibodies. Are they against a thymic epithelial antigen or against the cerebellar degeneration-related protein 2, 62kDa?
Yes, the specific antibody you have inquired about is against cerebellar degeneration-related protein 2, 62 kDa. Moreover, all of our CDR2 primaries are against the same target.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our CDR2 Antibody (33) and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.